Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human anthrax immunoglobulin

EU orphan designation number: EU/3/09/691
Active ingredient: Human anthrax immunoglobulin
Indication: Treatment of inhalation anthrax disease
Sponsor: Emergent Sales and Marketing Germany GmbH
Walter-Gropius-Straße 17, 80807 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/11/2009 Orphan designation EMEA/OD/065/09 (2009)8717 of 05/11/2009
26/04/2016 Removal of orphan designation from Community Register